摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-cinnamoylphenothiazine | 62829-70-3

中文名称
——
中文别名
——
英文名称
N-cinnamoylphenothiazine
英文别名
(E)-1-(10H-phenothiazin-10-yl)-3-phenylprop-2-en-1-one;(E)-1-phenothiazin-10-yl-3-phenylprop-2-en-1-one
N-cinnamoylphenothiazine化学式
CAS
62829-70-3
化学式
C21H15NOS
mdl
——
分子量
329.422
InChiKey
ISOJHRMKEGMVKU-CCEZHUSRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    139-140 °C(Solv: ethanol (64-17-5))
  • 沸点:
    509.7±43.0 °C(Predicted)
  • 密度:
    1.283±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    45.6
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:9e4f89346aeeb326cf99b971c4af794e
查看

反应信息

  • 作为反应物:
    描述:
    N-(4-氯苯基)-3-肼基-3-氧代丙酰胺N-cinnamoylphenothiazine溶剂黄146 作用下, 以 1,4-二氧六环 为溶剂, 反应 5.0h, 以27.9%的产率得到N-(4-chlorophenyl)-3-oxo-3-(5-phenothiazin-10-yl-3-phenyl-3,4-dihydropyrazol-2-yl)propanamide
    参考文献:
    名称:
    Jolly; Arora; Agarwal, Journal of the Indian Chemical Society, 1990, vol. 67, # 11, p. 922 - 923
    摘要:
    DOI:
  • 作为产物:
    描述:
    吩噻嗪3-苯基-2-丙烯酰氯三乙胺 作用下, 以 1,4-二氧六环 为溶剂, 反应 2.0h, 以95%的产率得到N-cinnamoylphenothiazine
    参考文献:
    名称:
    Jolly; Arora; Agarwal, Journal of the Indian Chemical Society, 1990, vol. 67, # 11, p. 922 - 923
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine
    作者:Sultan Darvesh、Robert S. McDonald、Katherine V. Darvesh、Diane Mataija、Sarah Conrad、Geraldine Gomez、Ryan Walsh、Earl Martin
    DOI:10.1016/j.bmc.2007.06.060
    日期:2007.10
    Evidence suggests that specific inhibition of butyrylcholinesterase may be an appropriate focus for the development of more effective drugs to treat dementias such as Alzheimer's disease. Butyrylcholinesterase is a co-regulator of cholinergic neuro-transmission and its activity is increased in Alzheimer's disease, and is associated with all neuropathological lesions in this disease. Some selective butyrylcholinesterase inhibitors have already been reported to increase acetylcholine levels and to reduce the formation of abnormal amyloid found in Alzheimer's disease. Synthesized N-(10)-aryl and N-(10)-alkylaryl amides of phenothiazine are specific inhibitors of butyrylcholinesterase. In some cases, inhibition constants in the nanomolar range are achieved. Enzyme specificity and inhibitor potency of these molecules can be related to molecular volumes, steric and electronic factors. Computed logP values indicate high potential for these compounds to cross the blood-brain barrier. Use of such butyrylcholinesterase inhibitors could provide direct evidence for the importance of this enzyme in the normal nervous system and in Alzheimer's disease. (C) 2007 Elsevier Ltd. All rights reserved.
  • JOLLY, V. S.;ARORA, G. D.;AGARWAL, LILY, J. INDIAN CHEM. SOC., 67,(1990) N1, C. 922-923
    作者:JOLLY, V. S.、ARORA, G. D.、AGARWAL, LILY
    DOI:——
    日期:——
  • Jolly; Arora; Agarwal, Journal of the Indian Chemical Society, 1990, vol. 67, # 11, p. 922 - 923
    作者:Jolly、Arora、Agarwal
    DOI:——
    日期:——
查看更多